HIGHLIGHTS
- who: Osteosarcoma and collaborators from the Wuhan Fourth Hospital, Department of Pulmonary and Critical Care Medicine, Wuhan, Hubei, China have published the paper: Genetics and Molecular Biology, in the Journal: (JOURNAL)
- what: The authors show that niclosamide at sub-micromolar concentrations inhibits proliferation and migration and induces apoptosis in both parental and chemo-resistant cells with much less toxicity in normal osteoblastic cells. The work provides pre-clinical evidence that niclosamide can be repurposed for treating the findings also suggest the therapeutic value of to overcome chemo-resistance. The authors evaluated niclosamide as a potential . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.